Quechen Silica: Company Overview, Product Range and Applications

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: What Is Fused Quartz? Properties, Manufacturing Process and Applications
  • Keywords: quartz powder for ceramics
  • Published: 2026-11-20 12:21:18
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Geng, S. et al. Effective and secure delivery of GLP-1AR and FGF-21 plasmids using amino-functionalized dual-mesoporous silica nanoparticles in vitro and in vivo. Biomaterials 271, 120763 (2021). Article CAS PubMed Google Scholar

Alumina Powder vs Silica Powder: Properties, Uses and How to Choose

What Is Silica Sand? Composition, Grades, Mesh Sizes and Industrial Uses
Spherical Silica Powder: Specifications, Particle Sizes and How to Choose the Right Grade
Yang, Y. et al. Red-light-triggered self-destructive mesoporous silica nanoparticles for cascade-amplifying chemo-photodynamic therapy favoring antitumor immune responses. Biomaterials 281, 121368 (2022). Article CAS PubMed Google Scholar
What Is Hydrophilic Silica? Properties, Grades and Applications
What Is Tetraethyl Orthosilicate? Properties, Uses and Role in Silica Synthesis
Wan, Y. & Zhao, D. On the controllable soft-templating approach to mesoporous silicates. Chem. Rev. 107, 2821-2860 (2007). Post CAS PubMed Google Scholar

Silica vs Silicone: Key Differences in Structure, Properties and Uses

What is silica (SiO₂)?

silicosis Besides the aforementioned metal sulfide NPs, the titanium nitride (TiN) NPs are also considered as a promising photothermal agent due to their high plasmonic absorption in the NIR region. 188 It is worth noting that the silica coating may be beneficial to boost the photothermal conversion performance of TiN NPs. 153, 189 Gschwend et al. found that the plasmonic performance of silica-coated TiN NPs was much higher than that of bare TiN NPs, because of the reduced plasmonic coupling effects. The optimized nanocomposite demonstrated a photothermal conversion efficiency of up to 58.5%, much higher than that of Au nanoshells that were used in the clinical trials and other commonly used inorganic photothermal agents. 153 Besides, Chen's group has reported the synthesis of a series of MSNs-coated transition metal carbide nanostructures, such as Nb 2 C and Ti 3 C 2 with different surface modifications. 166, 167, 175, 190, 191 These nanocomposites were demonstrated to show excellent photothermal properties, and realized the efficient combination of multiple therapeutic modalities through MSNs-mediated targeted drug delivery, thus supplying some new solutions for the illness diagnosis and treatment.

What is the difference between fumed silica and precipitated silica?

silica supply chain Clinical trials involving mesoporous silica have been ongoing since 2007, discussing its potential in diverse biomedical applications (Table 3 ). To date, the clinical trials have revealed the safety and good tolerability of silica in human subjects. In 2014, MSNs as oral delivery carriers for boosting the pharmacokinetic profile of drugs with limited aqueous solubility were reported. 500 A silica NPs-lipid hybrid formulation loading with ibuprofen (Lipoceramic-IBU) was prepared. The randomized, double-blind, single-dose oral administration study (20 mg ibuprofen) was conducted on 16 healthy male volunteers. The bioavailability of Lipoceramic-IBU was found to be 1.95 times higher than that of the commercial tablet Nurofen. 500 This result suggested the secure and effective use of silica-based NPs in mimicking food impacts to optimize the oral absorption of drugs with poor water solubility. In another clinical trial consisting of 12 participants in 2016, the bioavailability of ordered MSNs-based fenofibrate formulation raised by 54.1% after a single oral dose, when compared to the commercial formulation Lipanthyl. 39 Owing to the potentially perfect clinical outcomes of silica-based nanocarriers, the pharmacokinetics, safety, and metabolic profile of a hybrid core-shell silica NP (named Cornell dots, C dots) with a diameter of 6 nm functionalized with 124 I, targeting peptide cyclo-(Arg-Gly-Asp-Tyr), and Cy5 ( 124 I-cRGDY-PEG-C' dots) is first conducted in humans utilizing PET imaging and clinical tracer at clinical trials in 2014 (NCT01266096). 58 Results showed the good safety and reproducible PK signatures of C dots with the whole-body clearance half-time of 13-21 h after intravenous administration in patients, which is shorter than 111 In labeled liposomes and 131 I-labeled humanized monoclonal antibody A33. These findings verified the possibility of these NPs for cancer diagnostics in humans. 58 Similarly, 8 nm core-shell silica NPs encapsulated with Cy5.5 in the core and connected with cRGDY on the surface (cRGDY-PEG-Cy5.5-nanoparticles) were used in patients at nanomole doses for sentinel lymph nodes detection of head and neck melanoma at a phase 1/2 human clinical trial. 501 The incredible safety, accuracy, reliability, and high contrast of these particles for visual identification of sentinel lymph nodes are irreplaceable by other available imaging molecules presently, of which phase 2 clinical trial is ongoing and will be finished in 2024 (NCT02106598). Meanwhile, another two clinical trials based on C dots are carried out. In 2018, the 89 Zr-DFO-cRGDY-PEG-Cy5-C' dots tracers were first used in both surgical and non-surgical patients for PET-CT imaging of malignant brain tumors in phase 1 clinical trial (NCT03465618). The distribution and removal profiles from the body of these particles will also be assessed till 2023. In 2019, 64 Cu-NOTA-PSMA-PEG-Cy5.5-C' dots tracer was used in another human phase 1 clinical trial for guiding the surgery of prostate cancer by PET and MRI imaging (NCT04167969).As a nanocomposite with high safety and brilliant photothermal conversion efficiency, the silica-gold NPs have also been shown to be potential therapeutic agents for plasmonic photothermal therapy of atherosclerosis (NCT01270139), 502, 503 and photothermal ablation of tumors (NCT00848042, NCT04240639). 40 In addition, an engineered mesoporous silica (SiPore15) with particle size of 1.1-1.5 μm × 0.2-0.4 μm was developed by Baek et al., and they revealed that such pure synthetic amorphous silica could remarkably decrease long-term blood glucose levels, showing good promise for the treatment of prediabetes (NCT03823027). 504 In other clinical trials, an amorphous silica-containing bioactive scaffold, called Siloss, was used to promote bone regeneration, and could be replaced by natural bone due to its fully resorbable nature (NCT02639572), and the silica-calcium phosphate nanocomposite (SCPC) was developed as graft material for the reconstruction of the volume-deficient alveolar ridges (NCT05317039). In all, these clinical trials reveal the safety and efficacy of MSNs in diverse biomedical application scenarios.

What drives silica raw material prices?

thermal conductive filler National Center for Orthopaedics, Beijing Research Institute of Traumatology and Orthopaedics, Beijing Jishuitan Hospital, 100035, Beijing, China Rui Shi

Cite this article: Silica Raw Materials News. "How Is Silica Made? Production Methods for Each Type of Silica ." Published 2026-11-20 12:21:18. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.